CASO CLÍNICO
Vinflunina más trastuzumab en cáncer de vejiga Her2 positivo previamente tratado: reporte de un caso
Vinflunine plus trastuzumab in previously treated Her2 positive bladder cancer: A case report
a Departamento de Oncología Médica, Hospital de Oncología, Centro Médico Nacional SXXI, Ciudad de México, México
b Sociedad Mexicana de Oncología, Ciudad de México, México
c Centro de Cáncer, Centro Médico ABC, Ciudad de México, México
d Instituto Estatal de Cancerología de Colima, Colima, México
e Hospital General de Zona N.°1 IMSS Colima, Colima, México
Leído
5017
Vecesse ha leído el artículo
1083
Total PDF
3934
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 17 | 3 | 20 |
| 2025 11 | 50 | 31 | 81 |
| 2025 10 | 35 | 8 | 43 |
| 2025 9 | 50 | 20 | 70 |
| 2025 8 | 43 | 7 | 50 |
| 2025 7 | 40 | 6 | 46 |
| 2025 6 | 33 | 2 | 35 |
| 2025 5 | 42 | 6 | 48 |
| 2025 4 | 59 | 9 | 68 |
| 2025 3 | 46 | 12 | 58 |
| 2025 2 | 31 | 7 | 38 |
| 2025 1 | 37 | 5 | 42 |
| 2024 12 | 35 | 32 | 67 |
| 2024 11 | 36 | 12 | 48 |
| 2024 10 | 46 | 6 | 52 |
| 2024 9 | 51 | 11 | 62 |
| 2024 8 | 33 | 11 | 44 |
| 2024 7 | 36 | 8 | 44 |
| 2024 6 | 63 | 10 | 73 |
| 2024 5 | 46 | 4 | 50 |
| 2024 4 | 40 | 14 | 54 |
| 2024 3 | 44 | 7 | 51 |
| 2024 2 | 95 | 10 | 105 |
| 2024 1 | 53 | 8 | 61 |
| 2023 12 | 54 | 7 | 61 |
| 2023 11 | 38 | 12 | 50 |
| 2023 10 | 75 | 19 | 94 |
| 2023 9 | 38 | 3 | 41 |
| 2023 8 | 40 | 7 | 47 |
| 2023 7 | 51 | 3 | 54 |
| 2023 6 | 41 | 4 | 45 |
| 2023 5 | 67 | 6 | 73 |
| 2023 4 | 87 | 9 | 96 |
| 2023 3 | 67 | 6 | 73 |
| 2023 2 | 44 | 6 | 50 |
| 2022 1 | 41 | 3 | 44 |
| 2022 12 | 33 | 6 | 39 |
| 2022 11 | 47 | 8 | 55 |
| 2022 10 | 45 | 11 | 56 |
| 2022 9 | 33 | 14 | 47 |
| 2022 8 | 31 | 9 | 40 |
| 2022 7 | 37 | 8 | 45 |
| 2022 6 | 30 | 9 | 39 |
| 2022 5 | 26 | 10 | 36 |
| 2022 4 | 44 | 10 | 54 |
| 2022 3 | 38 | 10 | 48 |
| 2022 2 | 37 | 6 | 43 |
| 2021 1 | 59 | 15 | 74 |
| 2021 12 | 28 | 13 | 41 |
| 2021 11 | 31 | 10 | 41 |
| 2021 10 | 39 | 15 | 54 |
| 2021 9 | 40 | 12 | 52 |
| 2021 8 | 40 | 5 | 45 |
| 2021 7 | 30 | 10 | 40 |
| 2021 6 | 30 | 6 | 36 |
| 2021 5 | 26 | 7 | 33 |
| 2021 4 | 88 | 27 | 115 |
| 2021 3 | 85 | 7 | 92 |
| 2021 2 | 32 | 7 | 39 |
| 2020 1 | 52 | 8 | 60 |
| 2020 12 | 42 | 12 | 54 |
| 2020 11 | 38 | 10 | 48 |
| 2020 10 | 28 | 7 | 35 |
| 2020 9 | 23 | 6 | 29 |
| 2020 8 | 30 | 9 | 39 |
| 2020 7 | 21 | 4 | 25 |
| 2020 6 | 26 | 7 | 33 |
| 2020 5 | 24 | 4 | 28 |
| 2020 4 | 19 | 7 | 26 |
| 2020 3 | 33 | 10 | 43 |
| 2020 2 | 26 | 3 | 29 |
| 2020 1 | 22 | 11 | 33 |
| 2019 12 | 22 | 12 | 34 |
| 2019 11 | 22 | 4 | 26 |
| 2019 10 | 33 | 8 | 41 |
| 2019 9 | 36 | 15 | 51 |
| 2019 8 | 25 | 4 | 29 |
| 2019 7 | 23 | 8 | 31 |
| 2019 6 | 94 | 23 | 117 |
| 2019 5 | 188 | 10 | 198 |
| 2019 4 | 54 | 15 | 69 |
| 2019 3 | 13 | 8 | 21 |
| 2019 2 | 17 | 13 | 30 |
| 2019 1 | 20 | 4 | 24 |
| 2018 12 | 11 | 6 | 17 |
| 2018 11 | 13 | 1 | 14 |
| 2018 10 | 14 | 11 | 25 |
| 2018 9 | 18 | 7 | 25 |
| 2018 8 | 4 | 7 | 11 |
| 2018 7 | 2 | 3 | 5 |
| 2018 6 | 5 | 4 | 9 |
| 2018 5 | 20 | 8 | 28 |
| 2018 4 | 18 | 0 | 18 |
| 2018 3 | 3 | 3 | 6 |
| 2018 2 | 7 | 1 | 8 |
| 2018 1 | 3 | 0 | 3 |
| 2017 12 | 6 | 3 | 9 |
| 2017 11 | 11 | 2 | 13 |
| 2017 10 | 9 | 1 | 10 |
| 2017 9 | 10 | 8 | 18 |
| 2017 8 | 10 | 5 | 15 |
| 2017 7 | 8 | 3 | 11 |
| 2017 6 | 18 | 36 | 54 |
| 2017 5 | 14 | 7 | 21 |
| 2017 4 | 12 | 3 | 15 |
| 2017 3 | 18 | 119 | 137 |
| 2017 2 | 18 | 3 | 21 |
| 2016 1 | 9 | 2 | 11 |
| 2016 12 | 13 | 9 | 22 |
| 2016 11 | 41 | 19 | 60 |
| 2016 10 | 46 | 15 | 61 |
| 2016 9 | 7 | 4 | 11 |
| 2016 8 | 2 | 2 | 4 |
Mostrar todo